IMP — Vietnamese Stock News

1 published articles · Dược phẩm Imexpharm.

Imexpharm (IMP) Executives Register to Sell Shares for Personal Financial Planning

Imexpharm (IMP) CEO and two Deputy CEOs register to sell 607,400 shares from mid-April to mid-May 2026, citing personal financial reasons. The HoSE-listed pharmaceutical firm targets record 2026 revenue of VND 3,200B.

2026-04-15

IMP full analysis All stocks All sectors

Information provided for educational purposes only. Past performance does not guarantee future results. Data sourced from public Vietnamese market feeds.

Last updated: 2026-04-19T13:57:48.994597.

Imexpharm (IMP) Executives Register to Sell Shares for Personal Financial Planning